MD

Santiago Schiaffino is a Senior Director of Patient Safety Biopharma at AstraZeneca, with expertise in pharmacovigilance, pediatrics, and clinical pharmacology. They began their career as Chief of Residents at Hospital de Niños HNRG, serving from 2008 to 2009, and have held various roles, including Pediatrician at Hospital General de Niños “Ricardo Gutierrez” from 2009 to 2015. Santiago has contributed to the field through positions at Laboratorios Bagó and Boehringer Ingelheim, and has been involved in pharmacovigilance training and leadership across several organizations. They continue to advance their knowledge with ongoing education in medicine and project management.